ALGS vs GD · rev $3.6M vs P/E 22, rev $52.55B
Aligos Therapeutics Inc (ALGS) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
ALGS currently screens at market cap $44.1M. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the ALGS and GD stock pages for the full models.
Not investment advice.